Closed

DATACAP

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring: Pilot Study of Optimal Dose Scheduling of Capecitabine for Patients with Metastatic Colorectal or Metastatic Breast Cancer.
(click here for details)

Mobile Phone Project

Using GPRS mobile phone technology for managing symptoms associated with chemotherapy for colon cancer (The Mobile Phone Project)
(click here for details)

VICTOR

This is a phase III, randomised, double blind, placebo controlled study of VIOXX^® in colorectal cancer patients following potentially curative therapy.
(click here for details)